PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction

Kidney International

Volumn 60, Issue 2, 2001, Pages 587-596

  Oda, Takashi ^a   Jung, Young Ok ^a   Kim, Heung Soo ^a   Cai, Xiaohe ^a   López Guisa, Jesús M ^a   Ikeda, Yukiko ^a   Eddy, Allison A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Interstitial fibrosis; Macrophage; Myofibroblast; Plasminogen activator inhibitor 1; Renal fibrogenesis; Unilateral ureteral obstruction

Indexed keywords

MESSENGER RNA; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; FIBROGENESIS; INFLAMMATORY DISEASE; KIDNEY FIBROSIS; KIDNEY HOMOGENATE; MACROPHAGE MIGRATION; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; URETER OBSTRUCTION;

EID: 0034912450     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.030002587.x     Document Type: Article

References (41)

1. System USRD 1999 Annual data report
2. Experimental insights into the mechanisms of tubulo-interstitial scarring
3. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats
4. Experimental diffuse interstitial renal fibrosis: A biochemical approach
5. Biology and biochemistry of proteinases in tumor invasion
6. The plasminogen activator/plasmin system
7. Of mice and men: The function of plasminogen activator inhibitors (PAIs) in vivo
8. Expression of plasminogen activator-inhibitor-1 (PAI-1) during cellular remodeling in proliferative glomerulonephritis in the rat
9. Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type 1
10. Expression of type 1 plasminogen activator inhibitor in renal tissue in murine lupus nephritis
11. Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition
12. Extracellular matrix accumulation in immune-mediated tubulointerstitial injury
13. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis
14. TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat
15. New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy
16. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis
17. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization
18. Glomerular proliferating cell kinetics in acute post-streptococcal glomerulonephritis (APSGN)
19. Modifications of a specific assay for hydroxyproline in urine
20. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1
21. Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation
22. The kidney is a major site of α2-antiplasmin production
23. Cellular distribution of transforming growth factor-β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis
24. The mouse type-III procollagen-encoding gene: Genomic cloning and complete DNA sequence
25. cDNA cloning by PCR of rat transforming growth factor β-1
26. Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casin
27. A one-step, low background coomassie staining procedure for polyacrylamide gels
28. Amiloride selectively inhibits the urokinase-type plasminogen activator
29. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells
30. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration
31. Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis
32. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene
33. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin
34. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
35. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin
36. The urokinase-type plasminogen activator system in cancer metastasis: A review
37. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
38. The origin of the myofibroblasts in breast cancer: Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells
39. Progressive renal fibrosis in murine polycystic kidney disease: An immunohistochemical observation
40. Local macrophage proliferation in the progression of glomerular and tubulo-interstitial injury in rat anti-GBM glomerulonephritis
41. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption